In this program we discuss the determination of how specific patient
factors can help with the individualization of antihyperglycemic therapies
This course has expired. View available courses.
Endocrinology
Individualizing of Antihyperglycemic Agents in Type 2 Diabetes – Specialists
In this program we discuss the determination of how specific patient factors can help with the individualization of antihyperglycemic therapies
DURATION
15 minutes
PROFESSION
Specialist
# OF CREDITS
0.25
ACCREDITATION
MOC - Section 1
EXPIRY DATE
2020-11-26
In this program we discuss the determination of how specific patient
factors can help with the individualization of antihyperglycemic therapies
Faculty
David C.W. Lau (MD, PhD, FRCPC) David Strain (MB, ChB, BSc (Hons) MD, FRCP) Deanna Telner (MD, CCFP) Elizabeth Rosolowsky (MD, MPH, FAAP, FRCPC) Jeffrey Habert (MD, CCFP, FCFP) John Axler (MD, CCFP, FCFP) Peter J. Lin (MD, CCFP) Robyn L. Houlden (MD, FRCPC) Thomas Round (MBBS, BSc, DRCOG, MRCGP) |
Learning objectives
Upon completion of this program, participants will be able to:
1. Customize quickly and easily antihyperglycemic therapy for patients
Accreditation
This event is an accredited group learning activity under Section 1 as defined by the Royal College of Physicians & Surgeons of Canada for the Maintenance of Certification program. It is approved by the Canadian Society of Endocrinology and Metabolism for a maximum of 0.25 credit(s).
Cost of course:
Free
#
of credits: 0.25
Duration: 15 minutes